Trimethoprim sulfamethoxazole (co-trimoxazole) v placebo for HIV-1 infected patients with tuberculosis†
| Outcomes at median 10.5 mo | Co-trimoxazole | Placebo | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| †Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article. | ||||
| Death | 13.3% | 22.6% | 41% (19 to 57) | 11 (7 to 26) |
| ≥1 hospitalisation | 7.6% | 12.4% | 39% (5.6 to 61) | 21 (11 to 172) |